[Significance of biomarkers and surrogate endpoints in preclinical and clinical trials].
Ilić
Katarina
K
Farmaceutski fakultet, Vojvode Stepe 450, PO BOX 146, 11 221 Beograd, Srbija. kettyilic@hotmail.com
Kuntić
Vesna
V
D015415:Biomarkers; D035843:Biomedical Research; D002986:Clinical Trials as Topic; D006801:Humans
D015415:Biomarkers